Surveillance of High-Risk Type-16 and 18 Human Papillomavirus among HIV Positive and Non-Positive Individuals at Federal Teaching Hospital Ebonyi State Nigeria — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Surveillance of High-Risk Type-16 and 18 Human Papillomavirus among HIV Positive and Non-Positive Individuals at Federal Teaching Hospital Ebonyi State Nigeria
Department of Microbiology, Faculty of Biological Sciences, Alex-Ekwueme Federal University Ndufu-Alike, Ikwo, Nigeria
,
Department of Microbiology, Faculty of Biological Sciences, Alex-Ekwueme Federal University Ndufu-Alike, Ikwo, Nigeria
,
Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom
,
Park Hospital Burntstump Country Park, Sherwood Lodge Drive, Nottingham, United Kingdom
,
Department of Haematology, Faculty of Basic Clinical Sciences, Alex-Ekwueme Federal University Ndufu-Alike Ikwo, Abakaliki, Nigeria
,
Department of Stems Cell and Regenerative Medicine, University of Chester, Chester, United Kingdom
,
Department of Biotechnology, University of Chester, Chester, United Kingdom
,
Birmingham, West Midlands, United Kingdom
1 Department of Microbiology, Faculty of Biological Sciences, Alex-Ekwueme Federal University Ndufu-Alike, Ikwo, Nigeria
2 Department of Microbiology, Faculty of Biological Sciences, Alex-Ekwueme Federal University Ndufu-Alike, Ikwo, Nigeria
3 Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom
4 Park Hospital Burntstump Country Park, Sherwood Lodge Drive, Nottingham, United Kingdom
5 Department of Haematology, Faculty of Basic Clinical Sciences, Alex-Ekwueme Federal University Ndufu-Alike Ikwo, Abakaliki, Nigeria
6 Department of Stems Cell and Regenerative Medicine, University of Chester, Chester, United Kingdom
7 Department of Biotechnology, University of Chester, Chester, United Kingdom
This study was carried out to determine the seroprevalence of high risk human papillomavirus type-16 and type-18 among people living with HIV and individuals who are seronegative to HIV infection. A total of 400 Blood samples were collected from 200 persons living with HIV and 200 negative volunteers were analysed using the Enzyme Linked Immunosorbent Assay test. The positive samples were subjected to further tests using a Polymerase chain reaction with specific primers for human papillomavirus type-16 and type-18. Using the ELISA test, Human papillomavirus antibodies were detected in 180 (45%) of the samples, out of which 19 (10.6%) and 17 (9.4%) were positive using PCR with human papillomavirus type-16 and type-18 primers respectively. Furthermore, using the ELISA test, Human papillomavirus antibodies were highest among people living with HIV, age group 51 - 60 years 85 (47.2%), hotelier 73 (64.6%) and those living in the Urban 147 (47%). Traders were also found to have high level of human papillomavirus antibodies 41 (50.6%), while out of the 231 (57.7%) of the individuals that are married, 106 (45.9%) of them had human papillomavirus antibodies. Using PCR with HPV type-16 and HPV type-18 specific primers, the infection was found to be highest among individuals between 51 - 60 years with HPV type-16 being 69 (81.2%) while HPV type-18 was highest among the age group 41 - 50 having 11 (20%). This work shows that there is a need to include human papillomavirus screening as one of the vital tests since early detection of the presence of the virus helps in the reduction of the female mortality rate due to cervical cancer.
Boda, D., Docea, A., Calina, D., Ilie, M., Caruntu, C., Zurac, S., et al . (2018) Human Papilloma Virus: Apprehending the Link with Carcinogenesis and Unveiling New Research Avenues (Review). International Journal of Oncology , 52, 637-655. https://doi.org/10.3892/ijo.2018.4256
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA : A Cancer Journal for Clinicians , 68, 394-424. https://doi.org/10.3322/caac.21492
Jácome-Galarza, I., Ito-Nakashimada, M.A., Figueroa-Aguilar, G., García-Latorre, E., Salazar, M.I., López-Orduña, E., et al . (2017) Prevalence of Human Papillomavirus in Women from the State of Michoacan, Mexico, Showed High Frequency of Unusual Virus Genotypes. Revista de I nvestigación C línica , 69, 262-269. https://doi.org/10.24875/ric.17002065
Drolet, M., Bénard, É., Pérez, N., Brisson, M., Ali, H., Boily, M., et al . (2019) Population-Level Impact and Herd Effects Following the Introduction of Human Papillomavirus Vaccination Programmes: Updated Systematic Review and Meta-Analysis. The Lancet , 394, 497-509. https://doi.org/10.1016/s0140-6736(19)30298-3
Kjaer, S.K., Nygård, M., Dillner, J., Brooke Marshall, J., Radley, D., Li, M., et al . (2017) A 12-Year Follow-Up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clinical Infectious Diseases , 66, 339-345. https://doi.org/10.1093/cid/cix797
(2019) World Health Organization Estimates of Human Papillomavirus Immunization Coverage.
Forman, D., de Martel, C., Lacey, C.J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., et al . (2012) Global Burden of Human Papillomavirus and Related Diseases. Vaccine , 30, F12-F23. https://doi.org/10.1016/j.vaccine.2012.07.055
Dilley, S., Miller, K.M. and Huh, W.K. (2020) Human Papillomavirus Vaccination: Ongoing Challenges and Future Directions. Gynecologic Oncology , 156, 498-502. https://doi.org/10.1016/j.ygyno.2019.10.018
Herrera-Ortiz, A., Conde-Glez, C.J., Olamendi-Portugal, M.L., García-Cisneros, S., Plett-Torres, T. and Sánchez-Alemán, M.A. (2018) College Women, HPV Genotyping and Sexual Behavior before HPV Vaccination: Results from Samples Stored for a Long Time. Journal of Infection and Public Health , 11, 286-289. https://doi.org/10.1016/j.jiph.2017.08.014
Yang, J., Wang, W., Wang, Z., Wang, Z., Wang, Y., Wang, J., et al . (2019) Prevalence, Genotype Distribution and Risk Factors of Cervical HPV Infection in Yangqu, China: A Population-Based Survey of 10086 Women. Human Vaccines & Immunotherapeutics , 16, 1645-1652. https://doi.org/10.1080/21645515.2019.1689743
Dominguez Bauta, S.R., Trujillo Perdomo, T., Aguilar Fabré, K. and Hernandez Menendez, M. (2018) Infeccion por el virus del papiloma humano en adolescentes y adultas jovenes. Revista Cubana de Obstetricia y Ginecología , 44, 1-13.
Itarat, Y., Kietpeerakool, C., Jampathong, N., Chumworathayi, B., Kleebkaow, P., Aue-aungkul, A., et al . (2019) Sexual Behavior and Infection with Cervical Human Papillomavirus Types 16 and 18. International Journal of Women ’ s Health , 11, 489-494. https://doi.org/10.2147/ijwh.s218441
Basu, P., Malvi, S.G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., et al . (2021) Vaccine Efficacy against Persistent Human Papillomavirus (HPV) 16/18 Infection at 10 Years after One, Two, and Three Doses of Quadrivalent HPV Vaccine in Girls in India: A Multicentre, Prospective, Cohort Study. The Lancet Oncology , 22, 1518-1529. https://doi.org/10.1016/s1470-2045(21)00453-8
Whitworth, H.S., Gallagher, K.E., Howard, N., Mounier-Jack, S., Mbwanji, G., Kreimer, A.R., et al . (2020) Efficacy and Immunogenicity of a Single Dose of Human Papillomavirus Vaccine Compared to No Vaccination or Standard Three and Two-Dose Vaccination Regimens: A Systematic Review of Evidence from Clinical Trials. Vaccine , 38, 1302-1314. https://doi.org/10.1016/j.vaccine.2019.12.017
World Health Organisation (2024) United Nations General Assembly.
Kreimer, A.R., Herrero, R., Sampson, J.N., Porras, C., Lowy, D.R., Schiller, J.T., et al . (2018) Evidence for Single-Dose Protection by the Bivalent HPV Vaccine—Review of the Costa Rica HPV Vaccine Trial and Future Research Studies. Vaccine , 36, 4774-4782. https://doi.org/10.1016/j.vaccine.2017.12.078
Schwarz, T.F., Galaj, A., Spaczynski, M., Wysocki, J., Kaufmann, A.M., Poncelet, S., et al . (2017) Ten-Year Immune Persistence and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine in Females Vaccinated at 15-55 Years of Age. Cancer Medicine , 6, 2723-2731. https://doi.org/10.1002/cam4.1155
Enerly, E., Flingtorp, R., Christiansen, I.K., Campbell, S., Hansen, M., Myklebust, T.Å., et al . (2019) An Observational Study Comparing HPV Prevalence and Type Distribution between HPV-Vaccinated and-Unvaccinated Girls after Introduction of School-Based HPV Vaccination in Norway. PLOS ONE , 14, e0223612. https://doi.org/10.1371/journal.pone.0223612
Feiring, B., Laake, I., Christiansen, I.K., Hansen, M., Stålcrantz, J., Ambur, O.H., et al . (2018) Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years after Implementing HPV Vaccine in Norway. The Journal of Infectious Diseases , 218, 1900-1910. https://doi.org/10.1093/infdis/jiy432
Mariz, F.C., Bender, N., Anantharaman, D., Basu, P., Bhatla, N., Pillai, M.R., et al . (2020) Peak Neutralizing and Cross-Neutralizing Antibody Levels to Human Papillomavirus Types 6/16/18/31/33/45/52/58 Induced by Bivalent and Quadrivalent HPV Vaccines. NPJ Vaccines , 5, Article No. 14. https://doi.org/10.1038/s41541-020-0165-x
Monteiro, J.C., Fonseca, R.R.D.S., Ferreira, T.C.D.S., Rodrigues, L.L.S., da Silva, A.R.B., Gomes, S.T., et al . (2021) Prevalence of High Risk HPV in Hiv-Infected Women from Belém, Pará, Amazon Region of Brazil: A Cross-Sectional Study. Frontiers in Public Health , 9, Article 649152. https://doi.org/10.3389/fpubh.2021.649152
Ajang, A.Y., Ella, E.E., Oguntayo, A.O., Innocent, E. and Aminu, M. (2024) Prevalence of High-Risk HPV Types 16 and 18 in Relation to Immune Status and Cervical Cytological Profile of HIV-Infected Women on Antiretroviral Therapy in Northcentral Nigeria. African Journal of Clinical and Experimental Microbiology , 25, 248-261.
Bohlius, J., Foster, C., Naidu, G., Sengayi, M. and Turkova, A. (2018) Cancer in Adolescents and Young Adults Living with HIV. Current Opinion in HIV and AIDS , 13, 196-203. https://doi.org/10.1097/coh.0000000000000460
Cortés-Alaguero, C., González-Mirasol, E., Morales-Roselló, J. and Poblet-Martinez, E. (2017) Do Clinical Data and Human Papilloma Virus Genotype Influence Spontaneous Regression in Grade I Cervical Intraepithelial Neoplasia? Journal of the Turkish - German Gynecological Association , 18, 1-8. https://doi.org/10.4274/jtgga.2016.0138
Paluszkiewicz, A., Pruski, D., Iwaniec, K. and Kędzia, W. (2017) Comparison of the Diagnostic Value of Cervical Cytology and HPV HR DNA Testing for the Diagnosis of Low-Grade and High-Grade Squamous Intraepithelial Lesions across Different Age Groups. Ginekologia Polska , 88, 141-146. https://doi.org/10.5603/gp.a2017.0027
Teixeira, M.F., Sabidó, M., Leturiondo, A.L., de Oliveira Ferreira, C., Torres, K.L. and Benzaken, A.S. (2018) High Risk Human Papillomavirus Prevalence and Genotype Distribution among Women Infected with HIV in Manaus, Amazonas. Virology Journal , 15, Article No. 36. https://doi.org/10.1186/s12985-018-0942-6
Hidalgo-Tenorio, C., de Jesus, S.E., Esquivias, J. and Pasquau, J. (2018) High Prevalence and Incidence of HPV-Related Anal Cancer Precursor Lesions in HIV-Positive Women in the Late HAART Era. Enfermedades I nfecciosas y M icrobiologia C linica , 36, 555-562. https://doi.org/10.1016/j.eimce.2018.07.003
Chatha, Z.F., Rashid, U., Olsen, S., Din, F.u., Khan, A., Nawaz, K., et al . (2020) Pharmacist-led Counselling Intervention to Improve Antiretroviral Drug Adherence in Pakistan: A Randomized Controlled Trial. BMC Infectious Diseases , 20, Article No. 874. https://doi.org/10.1186/s12879-020-05571-w
Musumari, P.M., Srithanaviboonchai, K., Tangmunkongvorakul, A., Dai, Y., Sitthi, W., Rerkasem, K., et al . (2019) Predictors of Health-Related Quality of Life among Older Adults Living with HIV in Thailand: Results from the Baseline and Follow-Up Surveys. AIDS Care , 33, 10-19. https://doi.org/10.1080/09540121.2019.1707472